Clinical research

Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)

EuroIntervention 2010;5:906-916 - DOI10.4244/EIJV5I8A154.

Cosmo Godino
Cosmo Godino1,2*, MD; Guido Parodi3, MD; Shinichi Furuichi1, MD; Azeem Latib1, MD; Rossella Barbagallo4, MD; Omer Goktekin6, MD; Michela Cera1, MD; Ralf Mueller5, MD; Corrado Tamburino4, MD; Eberhard Grube5, MD; Carlo Di Mario6, MD; Bernard Reimers7, MD; Alaide Chieffo1, MD; David Antoniucci3, MD; Antonio Colombo1,2, MD; Giuseppe M. Sangiorgi8, MD
1. Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy; 2. EMO GVM Centro Cuore Columbus, Milan, Italy; 3. Division of Cardiology, Careggi Hospital, Florence, Italy; 4. Clinical Division of Cardiology, Ferrarotto Hospital, Catania, Italy;

Aims: Limited data are available on the long-term outcome following PCI with paclitaxel-eluting stent (PES) implantation in patients with unprotected left main coronary artery (LMCA). The o

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

coronary arteriescoronary stenosisrevascularisationstents
Read next article
Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial

Latest news